Oncology Analytics
As a clinical oncology pharmacist, Rebecca conducts high level reviews of patient information to determine the appropriateness of requested therapeutic agents. She is also responsible for alerting the OA team to any new medications, indications, and research associated with cancer treatment. She earned her Doctor of Pharmacy degree in 2008 from the University of South Carolina College of Pharmacy and then completed a residency at the University of Arizona Medical Center. In her prior position at Moffitt Cancer Center, she completed an Oncology Specialty Residency before transitioning into a clinical pharmacist role. She is currently a member of the University of South Florida’s Scientific Institutional Review Board.
This person is not in the org chart
This person is not in any offices
Oncology Analytics
Oncology Analytics, Inc. provides health plans with an evidence-based, technologically driven approach to utilization management, which is purpose-built for oncology. Used by physicians to support over 2.5 million health plan members in the US and Puerto Rico, the e-Prior Authorization platform is updated daily to accurately reflect more than 6,000 oncology treatment protocols for anti-cancer treatment across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy and supportive care